Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.271 USD | +2.46% | +2.65% | -33.90% |
06-26 | Cybin Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
06-11 | Cybin Inc. Appoints Atul R. Mahableshwarkar as Senior Vice President, Clinical Development | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.90% | 206M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- CYBN Stock
- News Cybin Inc.
- Canaccord Genuity Adjusts Price Target on Cybin to $5 From $6, Maintains Buy Rating